← Back to Clinical Trials
Recruiting NCT06641297

NCT06641297 White Matter Plasticity in Schizophrenia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06641297
Status Recruiting
Phase
Sponsor University of Maryland, Baltimore
Condition Schizophrenia Disorders
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2025-01-02
Primary Completion 2026-12-31

Trial Parameters

Condition Schizophrenia Disorders
Sponsor University of Maryland, Baltimore
Study Type INTERVENTIONAL
Phase N/A
Enrollment 36
Sex ALL
Min Age 15 Years
Max Age 45 Years
Start Date 2025-01-02
Completion 2026-12-31
Interventions
Music video game

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Schizophrenia spectrum disorders are associated with impairment in the microstructure of white matter, the key brain tissue responsible for fast communication between different brain regions necessary for any complex task. This white matter impairment is linked to problems with cognition in schizophrenia, especially slower processing speed. This project aims to study the potential for correcting white matter deficits in schizophrenia by examining mechanisms underlying white matter structure changes in response to training on playing a mock musical instrument.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or psychosis NOS * age 15-45 * able to provide informed consent Exclusion Criteria: * contraindications to MRI (metal implants, claustrophobia) * medical condition that limits use of hands (ie, arthritis) * Active or recent (within 6 months) substance use disorder other than nicotine

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology